Sattentau QJ - Search Results

1

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.

Sattentau QJ, Zolla-Pazner S, Poignard P. Sattentau QJ, et al. Virology. 1995 Jan 10;206(1):713-7. doi: 10.1016/s0042-6822(95)80094-8. Virology. 1995. PMID: 7530400 Free article.

2

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.

Sattentau QJ, Moore JP, Vignaux F, Traincard F, Poignard P. Sattentau QJ, et al. J Virol. 1993 Dec;67(12):7383-93. doi: 10.1128/JVI.67.12.7383-7393.1993. J Virol. 1993. PMID: 7693970 Free PMC article.

3

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.

Poignard P, Fouts T, Naniche D, Moore JP, Sattentau QJ. Poignard P, et al. Among authors: sattentau qj. J Exp Med. 1996 Feb 1;183(2):473-84. doi: 10.1084/jem.183.2.473. J Exp Med. 1996. PMID: 8627160 Free PMC article.

4

Antibody neutralization of HIV-1.

Poignard P, Klasse PJ, Sattentau QJ. Poignard P, et al. Among authors: sattentau qj. Immunol Today. 1996 May;17(5):239-46. doi: 10.1016/0167-5699(96)10007-4. Immunol Today. 1996. PMID: 8991386 Review.

5

Antibody neutralization of HIV-1 and the potential for vaccine design.

Sattentau QJ, Moulard M, Brivet B, Botto F, Guillemot JC, Mondor I, Poignard P, Ugolini S. Sattentau QJ, et al. Immunol Lett. 1999 Mar;66(1-3):143-9. doi: 10.1016/s0165-2478(98)00174-6. Immunol Lett. 1999. PMID: 10203047 Review.

6

Human and simian immunodeficiency viruses: virus-receptor interactions.

Signoret N, Poignard P, Blanc D, Sattentau QJ. Signoret N, et al. Among authors: sattentau qj. Trends Microbiol. 1993 Dec;1(9):328-33. doi: 10.1016/0966-842x(93)90072-y. Trends Microbiol. 1993. PMID: 8162421 Review.

7

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ. Parren PW, et al. Among authors: sattentau qj. Immunol Lett. 1997 Jun 1;57(1-3):105-12. doi: 10.1016/s0165-2478(97)00043-6. Immunol Lett. 1997. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. PMID: 9232434 Corrected and republished. Review.

8

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR. Parren PW, et al. Among authors: sattentau qj. Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. Immunol Lett. 1997. PMID: 9271324 Review.

9

Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Mondor I, Ugolini S, Sattentau QJ. Mondor I, et al. Among authors: sattentau qj. J Virol. 1998 May;72(5):3623-34. doi: 10.1128/JVI.72.5.3623-3634.1998. J Virol. 1998. PMID: 9557643 Free PMC article.

10

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.

Mondor I, Moulard M, Ugolini S, Klasse PJ, Hoxie J, Amara A, Delaunay T, Wyatt R, Sodroski J, Sattentau QJ. Mondor I, et al. Among authors: sattentau qj. Virology. 1998 Sep 1;248(2):394-405. doi: 10.1006/viro.1998.9282. Virology. 1998. PMID: 9721247 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page